Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atheroscleroris

Abstract

The invention relates to a terapeutical composition comprising a protein hydrolysate and a plant sterol, wherein the weight ratio of the plant sterol to the protein hydrolysate is from 1:0.02 to 1:150. The invention also relates to a terapeutical composition comprising a protein hydrolysate and a synthetic emulsifier and/or a lipid based grain fraction having emulsifying properties. Said compositions can be used in a pharmaceutical, nutraceutical or food product for improving serum lipid profile.

1 . A method of lowering serum triglycerides in a subject, comprising administering to the subject an oral therapeutical composition comprising a protein hydrolysate and a plant sterol, wherein the weight ratio of the plant sterol to the protein hydrolysate is from 1:0.02 to 1:150. 
   
   
       2 . The method according to  claim 1 , wherein the composition comprises an additional component selected from the group consisting of emulsifiers, fats, mineral salts and mixtures thereof. 
   
   
       3 . The method according to  claim 1 , wherein the plant sterol is selected from the group consisting of free sterols, free stanols, sterols in esterified form, stanols in esterified form and mixtures thereof. 
   
   
       4 . The method according to  claim 1 , wherein the protein hydrolysate is derived from vegetable or animal origin, including soybean protein, wheat protein, corn protein, oat protein, rye protein, rapeseed protein, barley protein, milk protein and mixtures thereof. 
   
   
       5 . The method according to  claim 2 , wherein the emulsifier is selected from the group consisting of monoglycerides, diglycerides, monoglyceride derivatives, lecithins, modified lecithins, polyglycerol esters, polyglycerol polyricinoleate, sorbitan esters, polysorbates, propylene glycol esters, stearoyl lactylates, diacetyl tartaric acid esters, diacetyl lactic acid esters, sucrose esters and mixtures thereof. 
   
   
       6 . The method according to  claim 2 , wherein the emulsifier has a hydrophilic lipophilic balance (HLB) of at least 4. 
   
   
       7 . The method according to  claim 1 , wherein the weight ratio of the plant sterol to the protein hydrolysate is from 1:0.2 to 1:30. 
   
   
       8 . The method according to  claim 2 , wherein the protein hydrolysate is in the form of a protein hydrolysate/emulsifier complex. 
   
   
       9 . The method according to  claim 8 , wherein the complex comprises at least 5%. 
   
   
       10 . The method according to  claim 2 , wherein the plant sterol is in the form of a plant sterol/emulsifier complex or dissolved or suspended in fat or a mixture of fat and an emulsifier. 
   
   
       11 . The method according to  claim 2 , wherein the protein hydrolysate and the plant sterol are in the form of a protein hydrolysate/plant sterol/emulsifier complex. 
   
   
       12 . The method according to  claim 10 , wherein the weight ratio of the plant sterol to emulsifier is from 1:0.01 to 1:5. 
   
   
       13 . The method according to  claim 2 , wherein the fat content is from 0 to 80% of the weight of the complex or suspension or solution. 
   
   
       14 . A method of lowering serum triglycerides in a subject, comprising administering to the subject an oral therapeutical composition comprising a protein hydrolysate and at least one emulsifier or a mixture of at least one emulsifier and a fat, wherein the emulsifier is a synthetic emulsifier. 
   
   
       15 . A method of lowering serum triglycerides in a subject, comprising administering to the subject an oral therapeutical composition comprising a protein hydrolysate and at least one emulsifier or a mixture of at least one emulsifier and a fat, wherein the emulsifier is a lipid based grain fraction having emulsifying properties. 
   
   
       16 . A method of lowering serum triglycerides in a subject, comprising administering to the subject a food product comprising at least one basic nutritional ingredient and an oral therapeutical composition comprising a protein hydrolysate and a plant sterol, wherein the weight ratio of the plant sterol to the protein hydrolysate is from 1:0.02 to 1:150. 
   
   
       17 . The method according to  claim 16 , wherein the food product is in the form of a product selected from the group consisting of bakery, confectionery, cereal, fermented cereal, snacks, beverage, dairy, sauce, soup, meat, fish, poultry, egg, soy based, vegetable oil based and ready mix products. 
   
   
       18 . The method according to  claim 16 , wherein the plant sterol content calculated as sterol equivalents is from 0.05 to 20 g per 100 g food product and the protein hydrolysate content is from 0.0002 to 20 g per 100 g food product. 
   
   
       28 . The method according to  claim 1 , wherein the protein hydrolysate is administrated at a rate of 0.1 to 60 g per day, and the plant sterol is administrated at a rate of 0.4 to 5 g per day calculated as sterol equivalents.